Summary
Rat brain cortex slices preincubated with 3H-serotonin were superfused with physiological salt solution containing the serotonin uptake blocker DU 24565 (6-nitroquipazine). The effects of (±)-cyanopindolol and its enantiomers, of ICI 118,551 (erythro-dl-1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol) and of isoprenaline on the electrically (3 Hz) evoked 3H overflow were studied.
(±)-Cyanopindolol increased the evoked 3H overflow; this effect was prevented by preexposure to the previously characterized serotonin receptor antagonist metitepin. The concentration-response curve of unlabelled serotonin for its inhibitory effect on the electrically evoked 3H overflow was shifted to the right by (±)-cyanopindolol (apparent pA2 value: 8.29), whereas that of noradrenaline (determined in the absence of DU 24565) was not affected (apparent pA2 value: <6.0). The concentration-response curve of serotonin was also shifted to the right by (−)-cyanopindolol (apparent pA2 value: 8.30) and (+)-cyanopindolol (6.83) but not by ICI 118,551 (<5.5). Isoprenaline (up to 10 μmol/l; examined in the absence of DU 24565) did not influence the electrically evoked 3H overflow.
The present results show that the presynaptic serotonin autoreceptor is blocked by cyanopindolol in a stereoselective way. This drug is 20 times more potent than metitepin as an antagonist at the presynaptic serotonin autoreceptor, and, in contrast to the latter, it does not act as an antagonist at the presynaptic α2-adrenoceptor on the serotoninergic neurone.
This is a preview of subscription content, log in via an institution to check access.
References
Baumann PA, Waldmeier PC (1981) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 317:36–43
Engel G, Göthert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983) Evidence for common pharmacological properties of [3H] 5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 324:116–124
Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1985) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
Frankhuyzen AL, Mulder AH (1980) Noradrenaline inhibits depolarization-induced 3H-serotonin release from slices of rat hippocampus. Eur J Pharmacol 63:179–182
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology, vol XXXIII. Catecholamines. Springer, Berlin Heidelberg New York, pp 283–335
Göthert M (1982) Modulation of serotonin release in the brain via presynaptic receptors. Trends Pharmacol Sci 3:437–440
Göthert M (1985) Effects of 5-hydroxytryptamine at presynaptic and neural sites. In: Bevan JA, Godfraind T, Maxwell RA, Stoclet JC, Worcel M eds) Vascular neuroeffector mechanisms. Elsevier. Amsterdam, pp 315–320
Göthert M, Weinheimer G (1979) Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 310:93–96
Héry F, Ternaux JP (1981) Regulation of release processes in central serotoninergic neurons. J Physiol (Paris) 77:287–301
Majewski H (1983) Modulation of noradrenaline release through activation of presynaptic β-adrenoceptors. J Autonom Pharmacol 3:47–60
Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch Pharmacol 321:165–170
Middlemiss DN (1984a) Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Eur J Pharmacol 101:289–293
Middlemiss DN (1984b) 8-Hydroxy-2-(di-n-propylamino)tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H]5-HT recognition site. Naunyn-Schmiedeberg's Arch Pharmacol 327:18–22
Middlemiss DN (1985) β-Adrenoceptor antagonists and blockade of the 5-HT autoreceptor in rat frontal cortex. Br J Pharmacol 84:189P
Middlemiss DN, Blakeborough L, Leather SR (1977) Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor. Nature 267:289–290
Misu Y, Kubo T (1983) Presynaptic β-adrenoceptors. Trends Pharmacol Sci 4:506–508
Nahorski SR, Willcocks AL (1984) Interactions of β-adrenoceptor antagonists with 5-hydroxytryptamine receptor subtypes in rat cerebral cortex. Br J Pharmacol 78:107P
Richards MH (1985) Efflux of 3H-5-hydroxytryptamine from rat hypothalamic slices by continuous electrical stimulation: frequency-dependent responses to serotonergic antagonists and 5-hydroxytryptamine. Naunyn-Schmiedeberg's Arch Pharmacol 329:359–366
Schlicker E, Göthert M (1981) Antagonistic properties of quipazine at presynaptic serotonin receptors and α-adrenoceptors in rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 317:204–208
Starke (1981) Presynaptic receptors. Annu Rev Pharmacol Toxicol 21:7–30
Author information
Authors and Affiliations
Additional information
This study was supported by a grant of the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Schlicker, E., Göthert, M. & Hillenbrand, K. Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 331, 398–401 (1985). https://doi.org/10.1007/BF00500826
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00500826